Published in Arch Neurol on January 10, 2011
Continued statin therapy could improve the outcome after spontaneous intracerebral hemorrhage. Neurosurg Rev (2012) 1.46
Apolipoprotein E, statins, and risk of intracerebral hemorrhage. Stroke (2013) 0.88
Statin discontinuation: counterbalancing the benefits with the potential risks. Arch Med Sci (2011) 0.87
Calculating the risk benefit equation for aggressive treatment of non-convulsive status epilepticus. Neurocrit Care (2013) 0.86
Cerebral microbleeds: a new dilemma in stroke medicine. JRSM Cardiovasc Dis (2012) 0.81
Statins and risk of poststroke hemorrhagic complications. Neurology (2016) 0.78
Statin treatment and intracerebral hemorrhage prognosis. Neurosurg Rev (2013) 0.77
Cortical superficial siderosis predicts early recurrent lobar hemorrhage. Neurology (2016) 0.77
Introduction to cerebral cavernous malformation: a brief review. BMB Rep (2016) 0.76
Statin Dose and the Risk of Intracerebral Hemorrhage: A Population-Based Longitudinal Study in Taiwan. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2016) 0.76
Florbetapir-PET to diagnose cerebral amyloid angiopathy: A prospective study. Neurology (2016) 0.75
Statins after intracerebral hemorrhage: to treat or not to treat. Arch Neurol (2011) 0.75
Rapidly Sequential and Fatal Hemorrhaging in a Case of Cerebral Amyloid Angiopathy. Am J Case Rep (2016) 0.75
Cerebral Amyloid Angiopathy in Stroke Medicine. Dtsch Arztebl Int (2017) 0.75
High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med (2006) 14.79
Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering. Ann Intern Med (2009) 3.83
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol (2001) 3.65
The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med (2004) 3.63
Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke (2003) 3.56
Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology (2007) 3.56
Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke (2002) 3.43
Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med (2000) 3.23
Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke (2003) 3.12
A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol Assess (2007) 2.62
Primer on medical decision analysis: Part 1--Getting started. Med Decis Making (1997) 2.61
Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology (2000) 2.59
Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke (1995) 2.08
Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Arch Intern Med (1999) 2.07
Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity. Ann Surg (2007) 1.75
Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation. Circulation (2001) 1.61
Prior statin use reduces mortality in intracerebral hemorrhage. Neurocrit Care (2008) 1.54
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins. Circ Res (1998) 1.53
Blood pressure control and recurrence of hypertensive brain hemorrhage. Stroke (1998) 1.46
Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage. Neurology (2001) 1.33
Effect of statins on intracerebral hemorrhage outcome and recurrence. Stroke (2008) 1.26
APOE genotype, ethnicity, and the risk of cerebral hemorrhage. Neurology (2008) 1.24
Prior statin use, intracranial hemorrhage, and outcome after intra-arterial thrombolysis for acute ischemic stroke. Stroke (2009) 1.14
Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease. J Thromb Haemost (2006) 1.10
Outcome of intracerebral haemorrhage patients pre-treated with statins. Eur J Neurol (2009) 1.09
Prior use of statins improves outcome in patients with intracerebral hemorrhage: prospective data from the National Acute Stroke Israeli Surveys (NASIS). Stroke (2009) 1.00
Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia. Arterioscler Thromb Vasc Biol (1995) 0.99
Lovastatin modulates in vivo and in vitro the plasminogen activator/plasmin system of rat proximal tubular cells: role of geranylgeranylation and Rho proteins. J Am Soc Nephrol (1998) 0.98
Prior use of statins and outcome in patients with intracerebral haemorrhage. Eur J Neurol (2009) 0.97
Recurrence of bleeding in patients with hypertensive intracerebral hemorrhage. Cerebrovasc Dis (1999) 0.96
Short-term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidaemia. CNS Drugs (2004) 0.94
Effects of long-term treatment with lovastatin on the clotting system and blood platelets. Ann Hematol (1992) 0.93
Statins and stroke prevention. Cerebrovasc Dis (2007) 0.91
Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitor. Thromb Res (1999) 0.87
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Curr Atheroscler Rep (2003) 0.87
Influence of withdrawal of statin treatment on proinflammatory response and fibrinolytic activity in humans: an effect independent on cholesterol elevation. Int J Cardiol (2005) 0.84
Atorvastatin: a pharmacoeconomic review of its use in the primary and secondary prevention of cardiovascular events. Pharmacoeconomics (2007) 0.83
Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology (2009) 0.83
Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance. Am J Hypertens (2004) 0.81
Statins, low cholesterol, and hemorrhagic stroke: an uncertain triangle. Neurology (2008) 0.80
Role of HMG-CoA reductase inhibitors in neurological disorders : progress to date. Drugs (2007) 0.80
Low cholesterol, statin therapy, and intracerebral haemorrhage. Hong Kong Med J (2009) 0.79
Treatment with cerivastatin in primary mixed hyperlipidemia induces changes in platelet aggregation and coagulation system components. Int J Hematol (2002) 0.79
The effects of atorvastatin treatment on the fibrinolytic system in dyslipidemic patients. Jpn Heart J (2004) 0.77
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature (2007) 8.03
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol (2007) 4.11
Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. Arch Neurol (2007) 3.83
The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med (2004) 3.63
Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med (2007) 3.61
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation. Ann Intern Med (2009) 3.44
Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke (2003) 3.12
Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med (2004) 3.06
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement (2011) 3.05
Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis (2006) 2.96
Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy. Ann Neurol (2005) 2.85
Cerebral amyloid angiopathy in the elderly. Ann Neurol (2011) 2.84
Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC score. Stroke (2008) 2.72
Enhanced neurosteroid potentiation of ternary GABA(A) receptors containing the delta subunit. J Neurosci (2002) 2.49
Disconnection of the ascending arousal system in traumatic coma. J Neuropathol Exp Neurol (2013) 2.38
Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol (2010) 2.31
Cerebral microinfarcts: the invisible lesions. Lancet Neurol (2012) 2.31
Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies. Ann Neurol (2013) 2.29
Confounding by indication in retrospective studies of intracerebral hemorrhage: antiepileptic treatment and mortality. Neurocrit Care (2012) 2.25
Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes (2010) 2.17
Nonexcitatory, cardiac contractility modulation electrical impulses: feasibility study for advanced heart failure in patients with normal QRS duration. Heart Rhythm (2006) 2.13
Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke (2008) 2.12
Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers. Arch Intern Med (2009) 2.08
Provisional vs. complex stenting strategy for coronary bifurcation lesions: meta-analysis of randomized trials. J Invasive Cardiol (2009) 2.03
Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol (2004) 1.95
The cerebral beta-amyloid angiopathies: hereditary and sporadic. Brain Pathol (2006) 1.91
Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation (2010) 1.90
Beta-amyloid, blood vessels, and brain function. Stroke (2009) 1.89
Apolipoprotein E genotype predicts hematoma expansion in lobar intracerebral hemorrhage. Stroke (2012) 1.89
Estimating cerebral microinfarct burden from autopsy samples. Neurology (2013) 1.87
Cerebral amyloid angiopathy: a systematic review. J Clin Neurol (2011) 1.77
The effect of survival bias on case-control genetic association studies of highly lethal diseases. Circ Cardiovasc Genet (2011) 1.71
Performance of the St. Jude Medical Riata leads. Heart Rhythm (2008) 1.71
Outcomes of hemodialysis patients in a long-term care hospital setting: a single-center study. Am J Kidney Dis (2009) 1.68
COL4A1 mutations in patients with sporadic late-onset intracerebral hemorrhage. Ann Neurol (2012) 1.62
Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Arch Neurol (2008) 1.60
Acute respiratory distress syndrome after spontaneous intracerebral hemorrhage*. Crit Care Med (2013) 1.58
Lack of replication in polymorphisms reported to be associated with atrial fibrillation. Heart Rhythm (2010) 1.58
Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. Brain (2007) 1.55
Underuse of controller medications among children with persistent asthma in the Ohio medicaid population: evolving differences with new medications. Ambul Pediatr (2005) 1.53
Should anticoagulation be resumed after intracerebral hemorrhage? Cleve Clin J Med (2010) 1.53
Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy. Ann Neurol (2010) 1.50
Early versus delayed bilateral subthalamic deep brain stimulation for parkinson's disease: a decision analysis. Mov Disord (2010) 1.48
APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study. Lancet Neurol (2011) 1.47
Descriptive analysis of the Boston criteria applied to a Dutch-type cerebral amyloid angiopathy population. Stroke (2009) 1.46
Cost-effectiveness of latent tuberculosis screening before steroid therapy for idiopathic nephrotic syndrome in children. Am J Kidney Dis (2012) 1.40
Propagation of uncertainty in Bayesian diagnostic test interpretation. South Med J (2012) 1.39
COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke. Am J Hum Genet (2011) 1.38
Neuroanatomic connectivity of the human ascending arousal system critical to consciousness and its disorders. J Neuropathol Exp Neurol (2012) 1.38
Validation of intracranial area as a surrogate measure of intracranial volume when using clinical MRI. J Neuroimaging (2007) 1.33
Topography of dilated perivascular spaces in subjects from a memory clinic cohort. Neurology (2013) 1.33
Hematoma expansion following acute intracerebral hemorrhage. Cerebrovasc Dis (2013) 1.30
Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy. Neurology (2012) 1.29
Functional magnetic resonance imaging detection of vascular reactivity in cerebral amyloid angiopathy. Ann Neurol (2012) 1.29
Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study. Ann Neurol (2013) 1.27
Effect of statins on intracerebral hemorrhage outcome and recurrence. Stroke (2008) 1.26
Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease. J Neurosci (2006) 1.24
Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy. Ann Neurol (2009) 1.23
MRI markers of small vessel disease in lobar and deep hemispheric intracerebral hemorrhage. Stroke (2010) 1.23
Emergence of stable functional networks in long-term human electroencephalography. J Neurosci (2012) 1.20
Apolipoprotein E genotype is associated with CT angiography spot sign in lobar intracerebral hemorrhage. Stroke (2012) 1.19
Tissue microstructural changes are independently associated with cognitive impairment in cerebral amyloid angiopathy. Stroke (2008) 1.19
Pentobarbital differentially modulates alpha1beta3delta and alpha1beta3gamma2L GABAA receptor currents. Mol Pharmacol (2004) 1.18
Anemia and hematoma volume in acute intracerebral hemorrhage. Crit Care Med (2009) 1.17
Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer's disease mouse models. Acta Neuropathol (2013) 1.15
CTA spot sign predicts hematoma expansion in patients with delayed presentation after intracerebral hemorrhage. Neurocrit Care (2012) 1.14
The impact of body posture and sleep stages on sleep apnea severity in adults. J Clin Sleep Med (2012) 1.14
Cerebrovascular lesions induce transient β-amyloid deposition. Brain (2011) 1.10
Power law versus exponential state transition dynamics: application to sleep-wake architecture. PLoS One (2010) 1.09
The genetic architecture of intracerebral hemorrhage. Stroke (2008) 1.08
Impact of bariatric surgery on life expectancy in severely obese patients with diabetes: a decision analysis. Ann Surg (2015) 1.08
Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice. J Neurochem (2009) 1.08
Antibody-mediated clearance of amyloid-beta peptide from cerebral amyloid angiopathy revealed by quantitative in vivo imaging. J Neurosci (2007) 1.07
Emergence of persistent networks in long-term intracranial EEG recordings. J Neurosci (2011) 1.07
White matter alterations in cerebral amyloid angiopathy measured by diffusion tensor imaging. Stroke (2006) 1.05
Dynamic single-section CT demonstrates reduced cerebral blood flow in acute intracerebral hemorrhage. Cerebrovasc Dis (2002) 1.04
Characteristic distributions of intracerebral hemorrhage-associated diffusion-weighted lesions. Neurology (2012) 1.03
CT angiography for intracerebral hemorrhage does not increase risk of acute nephropathy. Stroke (2009) 1.02
Heritability estimates identify a substantial genetic contribution to risk and outcome of intracerebral hemorrhage. Stroke (2013) 1.02
Principal-component analysis for assessment of population stratification in mitochondrial medical genetics. Am J Hum Genet (2010) 1.02
Spot sign score predicts rapid bleeding in spontaneous intracerebral hemorrhage. Emerg Radiol (2012) 1.01
Distribution of white matter hyperintensity in cerebral hemorrhage and healthy aging. J Neurol (2011) 1.01
Oral cyclophosphamide for active scleroderma lung disease: a decision analysis. Med Decis Making (2008) 1.01
Application of a decision support tool for anticoagulation in patients with non-valvular atrial fibrillation. J Gen Intern Med (2008) 1.01
Packed red blood cell transfusion and decreased mortality in intracerebral hemorrhage. Neurosurgery (2011) 1.01
Functional characterization of the new human GABA(A) receptor mutation beta3(R192H). Hum Genet (2002) 1.00
Red meets white: do microbleeds link hemorrhagic and ischemic cerebrovascular disease? Neurology (2009) 1.00
Progression of cerebral amyloid angiopathy in transgenic mouse models of Alzheimer disease. J Neuropathol Exp Neurol (2005) 0.99
Psychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarin. J Gen Intern Med (2005) 0.99
Aggressive care after a massive stroke in young patients: is that what they want? Neurocrit Care (2010) 0.99
Predictors of warfarin use among Ohio medicaid patients with new-onset nonvalvular atrial fibrillation. Arch Intern Med (2003) 0.98